Clinical Trial Update: A Study for Tysabri Participant Preference

View source ↗

Summary

This clinical trial update covers a study evaluating participant preferences for Tysabri (natalizumab) in Relapsing-Remitting Multiple Sclerosis. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis (RRMS) | Status: COMPLETED